Evotec AG (EVTG.F) Achieves Two Milestones in Fragment-based Drug Discovery Alliance With Shionogi & Co., Ltd.
10/27/2011 10:16:12 AM
HAMBURG, Germany, Oct. 27, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced the achievement of specific success criteria in a multiple target drug discovery collaboration with Shionogi & Co Ltd. and the receipt of two milestone payments. Evotec and Shionogi will continue to collaborate to progress the fragments through the drug discovery process.
comments powered by